
 
 
 
 
 
 
 
 
   
 1. Protein of Mycoplasma mycoides subsp. mycoides SC comprising the amino acid sequence as shown in table 5 (LppQ precursor, SEQ ID NO: 25), or parts thereof.  
 
     
 2. LppQ precursor protein of Mycoplasma mycoides subsp. mycoides SC characterised by the amino acid sequence as shown in table 5 (SEQ ID NO: 25).  
 
     
 3. Protein according to claim 1, wherein the parts are characterised by the amino acid sequences as shown in table 7 (mature LppQ, SEQ ID NO: 27), or table 9 (LppQN', SEQ ID NO: 29).  
 
     
 4. Mature LppQ protein of Mycoplasma mycoides subsp. mycoides SC characterised by the amino acid sequence as shown in table 7 (SEQ ID NO: 27).  
 
     
 5. N-terminal half of mature LppQ protein of Mycoplasma mycoides subsp. mycoides SC characterised by the amino acid sequence as shown in table 9 (LppQN'; SEQ ID NO: 29).  
 
     
 6. Protein according to any of claims 1 to 5, wherein said sequences are preceeded and / or followed by 2 to 12 histidine residues.  
 
     
 7. Protein according to any of claims 1 to 6, wherein the protein is a lipoprotein.  
 
     
 8. DNA encoding a protein according to any of claims 1 to 7.  
 
     
 9. DNA according to claim 8, characterised by the DNA sequence as shown in table 5 (IppQ precursor gene, SEQ ID NO: 24), table 6 (/ppQ*, SEQ ID NO: 26), or table 8 (IppQ*N', SEQ ID NO: 28). WO 01/40471 PCT/EPO0/1 1798 40  
 
     
 10. Use of a protein according .o any of claims 1 to 7 in a diagnostic method for the direct or indirect detection of Mycoplasma mycoides subsp. mycoides SC.  
 
     
 11. Use according to claim 10, wherein the diagnostic method is an immunological method and is selected from a group comprising immunoblotting, serological tests and ELISA.  
 
     
 12. Use of a protein according to any of claims 1 to 7 or a DNA according to any of claims 8 or 9 for the preparation of a vaccine against infection by Mycoplasma mycoides subsp. mycoides SC.  
 
     
 13. Use of a DNA according to any of claims 8 or 9 for the preparation of live, attenuated or inactivated cells of Mycoplasma mycoides subsp. mycoides SC to be used as marker vaccine, wherein said cells are lacking the ability to synthesise the LppQ lipoprotein.  
 
     
 14. Use of a DNA according to any of claims 8 or 9 in a detection method for Mycoplasma mycoides subsp. mycoides SC.  
 
     
 15. Use according to claim 14, wherein the detection method is selected from a group comprising PCR and hybridisation methods.  
 
     
 16. Use of a DNA according to any of claims 8 or 9 for the expression of a protein according to any of claims 1 to 7.  
 
     
 17. Vector comprising a DNA according to any of claims 8 or 9, in particular pJFFmaLP48-MuHisl (deposited at the European Collection of Cell Cultures, Salisbury, Wiltshire SP40JG.UK, deposition number: 99081025).  
 
     
 18. Host cell comprising a vector according to claim 17 or a DNA according to any of claims 8 or 9. WO 01/40471 PCT/IEPOO/11798 41  
 
     
 19. Process for the preparation of a protein according to any of claims 1 to 7, wherein (a) a vector according to claim 17 is introduced into a suitable host cell; (b) the host cell is cultivated under conditions allowing the expression of a protein according to any of claims 1 to 7; and (c) the protein of step (b) is isolated from the host cell or the supernatant.  
 
     
 20. Process for the preparation of a DNA characterised by the DNA sequence of table 5 (SEQ ID NO: 25), wherein (a) a DNA library of genomic DNA of Mycoplasma mycoides subsp. mycoides SC is cloned into a suitable phage; (b) the phage of step (a) is used for infecting suitable host cells; (c) the host cells are screened with sera from a mammal infected with Mycoplasma mycoides subsp. mycoides SC; (d) positive clones are selected and purified; and (e) the genomic DNA of the phage of step (d) is isolated.  
 
     
 21. Process for the preparation of a DNA characterised by the DNA sequence of table 6 (lppQ*, SEQ ID NO: 26), or table 8 (IppQ*N', SEQ ID NO: 28), wherein (a) a DNA characterised by the DNA sequence of table 5 (SEQ ID NO: 24) and suitable sets of primers according to table 3 (SEQ ID NOs: 1 to 4 and 6 to 21) are applied in an overlap extension PCR (OE - PCR) resulting in a first PCR product; (b) the PCR product of the OE - PCR of step (a) is applied in one or more OE PCR's as required by the number of desired mutations resulting in a final PCR product; and (c) the final PCR product is isolated.  
 
     
 22. Process for the detection of antibodies directed to a protein according to any of claims 1 to 5 and 7 in a body fluid from an animal, wherein (a) a protein according to any of claims 1 to 7 is blotted onto a suitable membrane; WO 01/40471 PCT/IEPOO/11798 42 (b) the membrane is incubated with said body fluid; (c) the membrane is incubated with a labelled conjugate; and (d) a colour reaction is initiated in order to detect a complex of the antibody of the conjugate and antibodies from the body fluid directed to a protein according to any of claims 1 to 5 and 7.  
 
     
 23. Process according to claim 22, wherein the body fluid is selected from a group comprising serum and bronchial fluid, the membrane is a nitro-cellulose or nylon membrane and the conjugate is labelled with alkaline phosphatase.  
 
     
 24. Process for the detection of antibodies directed to a protein according to any of claims 1 to 5 and 7 in a body fluid from an animal, wherein (a) a microtiter plate is coated with a protein according to any of claims 1 to 7; (b) the microtiter plate is incubated with said body fluid; (c) the microtiter plate is incubated with a labelled conjugate; and (d) a colour reaction is initiated in order to detect a complex of the antibody of the conjugate and antibodies from the body fluid directed to a protein according to any of claims 1 to 5 and 7.  
 
     
 25. Process according to claim 24, wherein the body fluid is selected from a group comprising serum and bronchial fluid and the conjugate is labelled with alkaline phosphatase.  
 
     
 26. Process for the detection of Mycoplasma mycoides subsp. mycoides SC, wherein (a) a pair of suitable PCR primers for the detection of a DNA according to table 5 (LppQ precursor gene, SEQ ID NO: 24) is used in a PCR reaction with a sample to be tested; and (b) after the PCR reaction the presence of the PCR product to be expected with the suitable pair of PCR primers is checked. WO 01/40471 PCT/IEPOO/11798 43  
 
     
 27. Process according to claim 26, wherein the suitable pair of PCR primers is selected from a group comprising the primers MMMSCO5-7 (SEQ ID NO: 22) and MMMSCO5-6 (SEQ ID NO: 23) as shown in Table 3. 
 
     
 * 28. Monoclonal antibody specific for a protein according to any of claims 1 to 7.  
 
     
 29. Diagnostic kit containing a protein according to any of claims 1 to 7 and / or at least one antibody according to claim 28 in a suitable container.  
 
     
 30. Vaccine comprising a protein according to any of claims 1 to 7 or a DNA according to any of claims 8 or 9 against infection by Mycoplasma mycoides subsp. mycoides SC. 
 
   
 
 
 
 
 
 
 
 
